Logo Cellply

Cellply invited to present at the World Health Summit 2019

Events

Cellply invited to present at the World Health Summit 2019

Cellply has been invited to present its innovation at the World Health Summit which will be held in Berlin on October 27-29, 2019.

The World Health Summit is one of the world’s leading conferences on global health issues bringing together researchers, physicians, key government officials, and representatives from industry, NGOs and healthcare systems to improve health globally.

Cellply will take part to the Entrpreneurs in Global Health program where a handful of top-rated startups have the opportunity to present their innovative ideas for future healthcare to international experts.

The World Health Summit is promoted under the auspices of Chancellor Angela Merkel, French President Emmanuel Macron and the President of the European Commission. The World Health Summit was founded in 2009 at the Charité. This year, 300 speakers and 2,500 participants from 100 nations are expected, including more than 10 ministers from around the world, top scientists, business and civil society leaders, WHO chiefs and World Bank vice-president.

Date of presentation: Monday, 28/10/2019, between 12:45-13:45
Venue: Kosmos | Karl-Marx-Allee 131a, Berlin

continue reading

You may also like

Webinar

Webinar: A new automated potency analysis technique for suspension cells

25 November 2024
Events

Cellply Named in Cohort 2 of EIC Scaling Club for EU Deep Tech Scale-ups

6 November 2024
Events

Cellply Introduces Revolutionary High-Throughput Potency Analysis Technique at SITC 39th Annual Meeting

31 October 2024
Webinar

Webinar: Uncovering hidden immune cell killing to understand anti-tumor activity

2 October 2024
Webinar

Cellply is pleased to announce its participation in European Biotech Week 2024 hosting an open webinar exploring the unique assay flexibility of VivaCyte

9 September 2024
News

Eurofins Biopharma Product Testing (BPT) Italy and Cellply announce strategic partnership to foster cell and gene therapy development through single-cell characterisation

29 August 2024
Webinar

Webinar: Rapid single cell functional characterization for cell therapy potency

12 July 2024
News

Cellply passed the phase 2 of Call4Innovit program and will go to San Francisco

23 May 2024
Events

Advancing TCR-based Cell Therapies & Bispecific Approaches

24 April 2024
Press release

Nature Biotechnology publishes research from DKFZ and Cellply highlighting novel approach for accelerating cellular immunotherapy development

19 March 2024
Events

Dual attendance for Cellply at March’s leading events in the cell therapy industry.

18 March 2024
Events

Launch of VivaCyte® at Advanced Therapies Week 2024

26 January 2024
News

Cellply launches its end-to-end single cell potency characterization platform VivaCyte

17 January 2024
Events

Cellply at Advanced Therapies Week 2024

4 January 2024
News

Cellply – Fesr programme 2021-2027

28 December 2023
Press release

Cellply concludes a new internal round of €3.6 million and extends the round to new investors!

27 September 2023
News

CellPly announces acceptance of one abstract at the CICON23 conference

18 September 2023
Press release

CellPly announces Emiliano Spagnolo as the new CEO

27 July 2023
News

L’innovazione Cellply in un articolo sulla rivista Le Scienze

4 March 2020
Events

Cellply to present new method for evaluating immunotherapy efficacy at the 61th ASH Annual Meeting

25 November 2019
News

Cellply wins the €300k Gaetano Marzotto prize and Unicredit StartLab prize

22 November 2018
News

Cellply selected as finalist at Lyfebulb Oncology Award

1 March 2018
Events

Cellply abstract accepted at the AACR 2018 Annual Meeting

4 February 2018
Press release

Cellply and Sant’Orsola-Malpighi Polyclinic to present one abstract on AML patient stratification with the Open Microwell platform at the 58th ASH Annual Meeting

4 November 2016
News

Cellply wins an H2020 SME Instrument Phase 1 grant

20 October 2016
Keep in touch

Need some infos?

Drop us a line or give us a ring. We love to hear from you and are happy to answer any questions.